Index Performance
-0.92%
MDBH
+7.24%
SPY
+4.16%
DIA
Overview
Description
Biotech companies between $30 million and $400 million market capitalization
- TickerMDBH
- Inception Date12/07/2023
- WeightingEqual
- # of holdings115
What's inside?
Holdings
All holdings as of May 17, 2024
CSV download
| Eliem Therapeutics, Inc. (ELYM) | 2.74% | $240.00M | N/A | N/A | N/A |
| ProKidney Corp. (DNAC) | 2.58% | $259.21M | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK) | 1.94% | $724.47M | -18.17% | 73.60% | 57.63 |
| Humacyte, Inc. (HUMA) | 1.75% | $753.80M | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN) | 1.53% | $249.14M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 1.49% | $652.02M | -100.00% | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI) | 1.41% | $137.31M | N/A | N/A | N/A |
| Galectin Therapeutics, Inc. (GALT) | 1.40% | $200.74M | N/A | N/A | N/A |
| Nuvation Bio, Inc. (NUVB) | 1.30% | $820.61M | N/A | N/A | N/A |
| Avid Bioservices, Inc. (CDMO) | 1.30% | $578.94M | -11.06% | 7.05% | 4.31 |
| XBiotech, Inc. (XBIT) | 1.27% | $256.76M | N/A | N/A | N/A |
| Aldeyra Therapeutics, Inc. (ALDX) | 1.26% | $234.69M | N/A | N/A | N/A |
| CorMedix, Inc. (CRMD) | 1.20% | $281.39M | N/A | N/A | N/A |
| Taysha Gene Therapies, Inc. (TSHA) | 1.20% | $577.89M | -27.52% | 90.47% | 42.38 |
| 23andMe Holding Co. (ME) | 1.18% | $185.10M | -33.15% | 28.20% | 1.11 |
| TScan Therapeutics, Inc. (TCRX) | 1.13% | $436.30M | -91.68% | -121.55% | 18.59 |
| Leap Therapeutics, Inc. (LPTX) | 1.06% | $100.64M | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB) | 1.05% | $139.32M | N/A | N/A | 1.70 |
| BioAtla, Inc. (BCAB) | 1.04% | $136.17M | N/A | N/A | N/A |
| Nautilus Biotechnology, Inc. (NAUT) | 1.03% | $369.53M | N/A | N/A | N/A |
| Affimed NV (AFMD) | 1.03% | $79.94M | -79.42% | N/A | -5.46 |
| Curis, Inc. (CRIS) | 1.02% | $69.55M | -9.19% | 77.71% | 6.60 |
| HOOKIPA Pharma, Inc. (HOOK) | 1.01% | $78.73M | 1,052.36% | 98.25% | 0.06 |
| MiNK Therapeutics, Inc. (INKT) | 1.01% | $35.07M | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO) | 1.01% | $76.22M | 18.26% | 32.20% | 1.30 |
| Precision BioSciences, Inc. (DTIL) | 0.98% | $85.88M | 100.27% | 91.88% | -0.66 |
| VistaGen Therapeutics, Inc. (VTGN) | 0.98% | $119.99M | 129.06% | 65.19% | 25.66 |
| Cognition Therapeutics, Inc. (CGTX) | 0.96% | $78.51M | N/A | N/A | N/A |
| Avrobio, Inc. (AVRO) | 0.96% | $62.40M | N/A | N/A | N/A |
| Seer, Inc. (California) (SEER) | 0.96% | $128.48M | -24.35% | -4.34% | -10.26 |
| Reneo Pharmaceuticals, Inc. (RPHM) | 0.94% | $58.49M | N/A | N/A | N/A |
| Vigil Neuroscience, Inc. (VIGL) | 0.94% | $132.30M | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX) | 0.94% | $482.09M | 17.07% | 75.64% | 3.99 |
| Verastem, Inc. (VSTM) | 0.94% | $291.24M | N/A | N/A | N/A |
| InflaRx NV (IFRX) | 0.92% | $95.98M | N/A | -511.93% | 11.55 |
| Co-Diagnostics, Inc. (CODX) | 0.91% | $34.09M | -58.01% | -123.58% | -2.13 |
| Black Diamond Therapeutics, Inc. (BDTX) | 0.91% | $273.95M | N/A | N/A | N/A |
| Graphite Bio, Inc. (GRPH) | 0.90% | $135.49M | N/A | N/A | N/A |
| Agenus, Inc. (AGEN) | 0.90% | $228.05M | 22.28% | 87.57% | 3.36 |
| Elutia, Inc. (AZYO) | 0.90% | $66.32M | -48.70% | 42.47% | 3.40 |
| X4 Pharmaceuticals, Inc. (XFOR) | 0.89% | $155.91M | N/A | N/A | N/A |
| AlloVir, Inc. (ALVR) | 0.89% | $87.65M | N/A | N/A | N/A |
| Poseida Therapeutics, Inc. (PSTX) | 0.89% | $309.29M | 172.09% | 95.10% | 2.33 |
| OncoCyte Corp. (OCX) | 0.88% | $39.16M | -40.74% | -190.34% | 19.76 |
| INmune Bio, Inc. (INMB) | 0.88% | $214.64M | -63.16% | N/A | 1,479.00 |
| Coeptis Therapeutics Holdings, Inc. (BHSE) | 0.87% | $13.00M | N/A | N/A | N/A |
| uniQure NV (QURE) | 0.87% | $243.23M | 59.34% | -39.72% | 12.55 |
| Precigen, Inc. (PGEN) | 0.86% | $348.34M | -42.46% | -76.10% | 59.44 |
| Athira Pharma, Inc. (ATHA) | 0.86% | $96.59M | N/A | N/A | N/A |
| Vor Biopharma, Inc. (VOR) | 0.84% | $123.55M | N/A | N/A | N/A |
| Foghorn Therapeutics, Inc. (FHTX) | 0.83% | $234.65M | -4.88% | 83.47% | 3.57 |
| Spruce Biosciences, Inc. (SPRB) | 0.83% | $30.87M | 1.93% | 99.25% | -4.41 |
| Instil Bio, Inc. (TIL) | 0.83% | $74.79M | N/A | N/A | N/A |
| ImmuCell Corp. (ICCC) | 0.82% | $37.58M | 110.58% | 31.63% | 2.65 |
| Jasper Therapeutics, Inc. (JSPR) | 0.82% | $347.27M | N/A | N/A | N/A |
| Ikena Oncology, Inc. (IKNA) | 0.82% | $69.01M | -100.00% | N/A | -20.55 |
| Shattuck Labs, Inc. (STTK) | 0.81% | $376.37M | 1,856.14% | 12.65% | 125.76 |
| Voyager Therapeutics, Inc. (VYGR) | 0.81% | $458.54M | -87.03% | 93.87% | 1.51 |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.81% | $145.67M | -100.00% | N/A | 23.19 |
| Enzo Biochem, Inc. (ENZ) | 0.81% | $55.84M | -47.65% | 49.39% | 0.18 |
| MeiraGTx Holdings Plc (MGTX) | 0.81% | $367.19M | -79.09% | -369.87% | 31.46 |
| LAVA Therapeutics NV (LVTX) | 0.80% | $69.40M | -65.09% | 29.68% | -6.95 |
| Xeris Biopharma Holdings, Inc. (XERS) | 0.80% | $293.55M | 22.42% | 78.64% | 2.87 |
| Spero Therapeutics, Inc. (SPRO) | 0.80% | $85.84M | 468.11% | N/A | 0.15 |
| Vaxart, Inc. (VXRT) | 0.79% | $169.55M | 223.11% | 49.56% | 23.24 |
| Neoleukin Therapeutics, Inc. (NLTX) | 0.79% | $428.40M | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG) | 0.79% | $81.37M | N/A | N/A | N/A |
| Aadi Bioscience, Inc. (AADI) | 0.79% | $46.90M | -8.76% | 87.82% | -0.76 |
| Kezar Life Sciences, Inc. (KZR) | 0.78% | $55.74M | N/A | N/A | -13.70 |
| Champions Oncology, Inc. (CSBR) | 0.77% | $63.89M | -5.90% | 34.70% | 1.67 |
| PepGen Inc. (PEPG) | 0.77% | $426.61M | N/A | N/A | N/A |
| CARA Therapeutics, Inc. (CARA) | 0.77% | $41.01M | -65.37% | 68.99% | 1.50 |
| Cyclo Therapeutics, Inc. (CYTH) | 0.76% | $40.06M | 32.83% | -313.18% | 33.20 |
| Larimar Therapeutics, Inc. (LRMR) | 0.76% | $470.84M | N/A | N/A | N/A |
| Prelude Therapeutics, Inc. (PRLD) | 0.76% | $168.32M | N/A | N/A | N/A |
| IO Biotech, Inc. (IOBT) | 0.75% | $90.92M | N/A | N/A | N/A |
| Sangamo Therapeutics, Inc. (SGMO) | 0.75% | $134.80M | -99.70% | -425.16% | 5.14 |
| Spyre Therapeutics, Inc. (AGLE) | 0.75% | $1.52B | -100.00% | N/A | 1,945.66 |
| Trevi Therapeutics, Inc. (TRVI) | 0.74% | $195.11M | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE) | 0.74% | $83.18M | 818.18% | 50.55% | 9.32 |
| ImmunoPrecise Antibodies Ltd. (IPA) | 0.73% | $31.05M | 19.97% | 39.99% | 3.01 |
| Altimmune, Inc. (ALT) | 0.73% | $567.93M | -76.19% | -2,040.00% | 1,315.24 |
| Monte Rosa Therapeutics, Inc. (GLUE) | 0.72% | $262.66M | N/A | -78.29% | 259.77 |
| Greenwich LifeSciences, Inc. (GLSI) | 0.72% | $180.04M | N/A | N/A | N/A |
| Compass Pathways Plc (CMPS) | 0.71% | $535.81M | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (CRTX) | 0.70% | $39.11M | N/A | N/A | N/A |
| Compugen Ltd. (CGEN) | 0.69% | $188.91M | 346.12% | 92.59% | 3.70 |
| Anixa Biosciences, Inc. (ANIX) | 0.69% | $90.91M | N/A | N/A | 562.51 |
| BioXcel Therapeutics, Inc. (BTAI) | 0.69% | $77.69M | 182.52% | 72.85% | 65.63 |
| Replimune Group, Inc. (REPL) | 0.68% | $395.51M | N/A | N/A | N/A |
| Adaptimmune Therapeutics Plc (ADAP) | 0.67% | $283.67M | -88.19% | 50.16% | 14.30 |
| Aspira Women's Health, Inc. (AWH) | 0.66% | $33.12M | -7.04% | 56.39% | 4.00 |
| HCW Biologics Inc. (HCWB) | 0.64% | $41.61M | 2,590.14% | 32.95% | 17.66 |
| BioVie, Inc. (BIVI) | 0.63% | $30.01M | N/A | N/A | N/A |
| Nascent Biotech, Inc. (NBIO) | 0.62% | $16.09M | N/A | N/A | N/A |
| Solid Biosciences, Inc. (SLDB) | 0.61% | $343.50M | N/A | N/A | N/A |
| Invivyd, Inc. (ADGI) | 0.60% | $286.36M | N/A | N/A | N/A |
| Omega Therapeutics, Inc. (OMGA) | 0.60% | $132.92M | 357.36% | 23.05% | 54.44 |
| SAB Biotherapeutics, Inc. (SABS) | 0.59% | $33.49M | -90.63% | -67.28% | -5.67 |
| C4 Therapeutics, Inc. (CCCC) | 0.57% | $390.82M | -19.15% | 33.30% | 18.50 |
| Ventyx Biosciences, Inc. (VTYX) | 0.55% | $333.46M | N/A | N/A | N/A |
| Immunome, Inc. (IMNM) | 0.55% | $829.37M | -56.47% | 74.44% | 76.01 |
| Gain Therapeutics, Inc. (GANX) | 0.55% | $47.48M | -100.00% | N/A | N/A |
| Carisma Therapeutics, Inc. (SESN) | 0.55% | $58.58M | 4.75% | 50.16% | 2.91 |
| Century Therapeutics, Inc. (IPSC) | 0.54% | $249.37M | -50.29% | -277.31% | 83.83 |
| Akoya Biosciences, Inc. (AKYA) | 0.52% | $140.75M | -14.29% | 45.66% | 2.72 |
| Kodiak Sciences, Inc. (KOD) | 0.51% | $173.37M | N/A | N/A | N/A |
| Mersana Therapeutics, Inc. (MRSN) | 0.49% | $334.05M | 18.50% | 95.42% | 10.29 |
| Nkarta, Inc. (NKTX) | 0.48% | $460.15M | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE) | 0.47% | $443.94M | -96.74% | -150.44% | 71.11 |
| Enlivex Therapeutics Ltd. (ENLV) | 0.31% | $26.22M | N/A | N/A | N/A |
| Gritstone bio, Inc. (GRTS) | 0.30% | $85.49M | -90.96% | -3,455.10% | 429.08 |
| Renovaro, Inc. (ENOB) | 0.27% | $143.08M | N/A | N/A | N/A |
| eFFECTOR Therapeutics, Inc. (EFTR) | 0.16% | $9.13M | N/A | N/A | N/A |
| Vaxxinity, Inc. (VAXX) | 0.10% | $10.27M | N/A | N/A | N/A |
Market data by FactSet
